Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

59
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
59
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

58
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

64
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Diagnosis in Cutaneous Head and Neck Squamous Cell Carcinoma.

Biomedicines·2026
Same author

Thyroid Lobectomy and Neck Dissection for N1b Papillary Thyroid Carcinoma.

JAMA otolaryngology-- head & neck surgery·2025
Same author

Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors.

Surgery·2025
Same author

Anaplastic Thyroid Carcinoma: A Contemporary Review of Challenges and Advances.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Updated Calcitonin Values for Prediction of Lymph Node Metastasis in Medullary Thyroid Cancer.

JAMA otolaryngology-- head & neck surgery·2025
Same author

Impact of artificial intelligence-based and traditional image preprocessing and resampling on MRI-based radiomics for classification of papillary thyroid carcinoma.

BJR artificial intelligence·2025

Related Experiment Video

Updated: May 7, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.4K

Thyroid metastasectomy.

Pablo H Montero1, Tihana Ibrahimpasic, Iain J Nixon

  • 1Head and Neck Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer, New York, New York.

Journal of Surgical Oncology
|October 15, 2013
PubMed
Summary

Thyroid gland metastases are rare, often originating from kidney, lung, breast, or colon cancers. Surgery may help manage complications, though it rarely cures the cancer.

Keywords:
metastasectomymetastasisthyroid cancerthyroid neoplasms/secondarythyroid surgery

More Related Videos

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

743
Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
05:10

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

2.5K

Related Experiment Videos

Last Updated: May 7, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.4K
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

743
Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
05:10

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

2.5K

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Oncology

Background:

  • Metastases to the thyroid gland are infrequent occurrences in clinical practice.
  • Common primary sites include renal, lung, breast, and colon cancers, as well as melanoma.
  • Existing literature consists of limited retrospective series, highlighting a need for further investigation.

Purpose of the Study:

  • To review the current understanding of thyroid metastases.
  • To discuss the individualized treatment strategies for patients with thyroid metastases.
  • To evaluate the role and aims of surgical intervention in managing thyroidal metastatic disease.

Main Methods:

  • This review synthesizes information from existing retrospective studies and case reports.
  • Analysis focuses on common primary cancer types and patient outcomes.
  • Treatment decision-making criteria, including surgical candidacy, are examined.

Main Results:

  • Renal, lung, breast, colon cancer, and melanoma are the most frequent origins of thyroid metastases.
  • Treatment is highly individualized, contingent upon the patient's overall systemic disease status.
  • Surgical intervention is considered for selected patients, primarily to mitigate complications.

Conclusions:

  • Thyroid metastases necessitate personalized treatment plans based on systemic disease.
  • Surgical management, while not curative for most, aims to prevent severe complications from uncontrolled neck disease.
  • Further research into optimal management strategies for this rare condition is warranted.